{
  "retracted": false,
  "timestamp": 1327968000000,
  "updates": [
    {
      "timestamp": 1556332904552,
      "identifier": {
        "doi": "10.1038/nrclinonc.2011.214"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/nrclinonc.2011.193"
  },
  "journal": "Nature Reviews Clinical Oncology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: Breast cancer: increasing therapy options for HER2-positive early breast cancer"
}
